Navigation Links
UCL academics awarded prestigious prizes for work on the heart

Two UCL academics have received prominent international awards from the European Society of Cardiology (ESC), in recognition of their work to understand and treat conditions of the heart.

Professor John Martin, Director of the UCL Centre for Cardiovascular Biology & Medicine and British Heart Foundation Professor of Cardiovascular Science, has been awarded the ESC's Gold Medal. The only other holder of this medal in the UK is Sir James Black, Nobel Laureate. Dr Paul Riley, UCL Institute of Child Health, has been awarded the Outstanding Achievement Award 2008 of the ESC Council on Basic Cardiovascular Science.

Commenting on the ESC awards, Professor Ed Byrne, Executive Dean of the UCL Faculty of Biomedical Sciences and Head of the Medical School, said: "Heart and circulatory disease is the UK's biggest killer and these awards demonstrate that UCL research is breaking new ground in the understanding and treatment of these conditions. I am delighted that the ESC has chosen to recognise the scientific endeavours of John and Paul and offer my sincere congratulations to them both."

Professor Martin has pursued an active research career, examining how the manufacture of platelets in the body causes blood to clot, how arteries age, and the protective role played by the gene for vascular endothelial growth factor (VEGF). His realisation that VEGF could be used therapeutically led him to start his own company, Ark Therapeutics, which is now taking gene therapy for vascular damage through clinical trials. He has also begun a phase III clinical trial to test whether the damage of heart attack can be repaired by direct injection of a patient's own bone marrow cells into the heart muscle.

Professor Martin also wrote the Heart Plan for Europe, a 'tool box' to help each country design its own bespoke prevention package for heart health, and he serves on a number of professional boards. As well as his scientific and medical endeavours, Professor Martin is a published writer and poet. He studied for his first degree in philosophy at a Spanish University and is fluent in Spanish and French, as well as being a keen artist.

The award made to Dr Paul Riley, Reader in the Molecular Medicine Unit at the UCL Institute of Child Health, recognises a landmark discovery in the field of basic cardiovascular science when his team found that a protein called Thymosin beta4 could mobilise dormant cells from the epicardium to form new blood vessels in the heart a major step towards finding a DIY mechanism to repair injury following heart attack.

Dr Riley said: "I'm very pleased indeed that my work has attracted professional recognition from the ESC." When not engaged in scientific pursuits, Dr Riley is a keen footballer, playing in an 8-a-side league with other scientists and clinicians close to the Institute in nearby Coram's Fields.


Contact: Ruth Metcalfe
University College London

Related medicine news :

1. SpectraScience Awarded Patent for Correcting Image Misalignment
2. Phoenix Health Systems Awarded Level 2 Carnegie Mellon University eSCM-SP Certification
3. ACS Awarded $4 Million Contract to Provide Electronic Patient Records for City of New Orleans EMS
4. Malaria Vaccine Developer Sanaria Inc. and the University of Maryland Biotechnology Institute Awarded Collaborative, Multi-Year, US $600,000 NIH Phase I Small Business Innovation Research Grant
5. Canica Design Awarded Milestone U.S. Patent for Dynamic Wound Closure Systems
6. Availity Awarded Full EHNAC Accreditation
7. All-Med Services of Florida Awarded Medicare Competitive Bidding Contract
8. Nyer Medical Group, Inc. Announces Sale of Companys Florida Medical-Surgical Division; Pharmacy Division Awarded Two-Year Preferred Supplier Contract
9. TruFUSE(R) Patents Awarded
10. Pioneering stroke researcher awarded Canadas highest honor
11. Pathway Medical Technologies Awarded New Patent for Pathway PV(TM) Atherectomy System for Improved Differential Cutting
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... According to an ... the University of Toronto and the University of British Columbia suggested that laws requiring ... injuries. The article explains that part of the reason for the controversial conclusion is ...
(Date:11/27/2015)... ... November 27, 2015 , ... A team of Swiss doctors has ... it. Surviving Mesothelioma has just posted the findings on the website. Click here ... the cases of 136 mesothelioma patients who were treated with chemotherapy followed by EPP ...
(Date:11/27/2015)... ... November 27, 2015 , ... Lizzie’s Lice Pickers just announced ... offering customers 10% off of their purchase of lice treatment product. In addition, customers ... According to a company spokesperson. “Finding lice is a sure way to ruin the ...
(Date:11/27/2015)... ... ... the No.1 Herpes-only dating community in the world, revealed that over 50% of its members ... billion people under the age of 50 – or 67% of the population - are ... of HSV-1 infection . , "The data shocks us highly!" said Michelle Li, Co-Founder ...
(Date:11/27/2015)... ... 2015 , ... A simply groundbreaking television series, "Voices in America", which is ... an array of issues that are presently affecting Americans. Dedicated to providing the world ... is changing the subjects consumers focus on, one episode at a time. , ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... Nov. 25, 2015  The American Academy of ... (ACOG), and the March of Dimes cheered today,s ... Our Infants Act of 2015 (S.799), which ... newborns born exposed to drugs, such as opioids, ... introduction, all three organizations have worked together leading ...
(Date:11/25/2015)... On Tuesday, November 24, 2015, the ... Wright Medical Technology, Inc. for product liability and ... implant device, awarded $11 million in favor of ... and three days of deliberations, the jury found ... designed and unreasonably dangerous, and that Wright Medical ...
(Date:11/25/2015)... , November 25, 2015 ... KTOV ) (TASE: KTOV), a biopharmaceutical company focused on ... of various clinical conditions, today announced the closing of ... Depository Shares ( ADSs ), each representing 20 ordinary ... to 3,158,900 ADSs. The ADSs and warrants were issued ...
Breaking Medicine Technology: